Drug intelligence / Profile preview

Aliatop crema

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Topical
01

Overview

Aliatop crema is a topical medical device developed by Epitech Group for the symptomatic treatment of itching, burning, irritation, and skin rashes associated with inflammatory, chronic, or relapsing erythematous-squamous dermatoses, such as atopic dermatitis, irritant contact dermatitis, and allergic contact dermatitis. The formulation contains a synergistic combination of active ingredients, including adelmidrol, phytosphingosine, hyaluronic acid, and sodium PCA. Adelmidrol, a synthetic aliamide derivative of azelaic acid, acts as a mast cell stabilizer and PPAR-gamma agonist to downregulate neuroinflammatory responses. Phytosphingosine helps control resident microbial flora and, together with hyaluronic acid, promotes physiological cell turnover and restores the skin barrier. Sodium PCA provides intense moisturizing and emollient effects to maintain skin hydration.

Brand names
AliatopAliatop cremaAliatop Crema FluidaAliatop Emulsione DetergenteAliatop JuniorAliatop Junior crema
02

Targets

CD44 (CD44 antigen)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on Aliatop crema.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aliatop crema.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call